Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

AAD: Clobetasol-Based Shampoo Beats Tar Shampoo For Scalp Psoriasis By Alison Palkhivala SAN FRANCISCO, CA -- March 25, 2003 -- A new formulation of clobetasol proprionate 0.05% shampoo appears to be just as safe and more effective than a tar blend shampoo for the treatment of moderate to severe scalp psoriasis. As part of a multi-centre trial, 162 individuals at least 18 years of age with moderate to severe scalp psoriasis were randomised in a 3:1 ratio to treatment with a new formulation of clobetasol proprionate 0.05% shampoo or a 1% tar blend shampoo. Participants applied their assigned shampoo once daily to a dry scalp for 15 minutes and then rinsed it off. S. Arsonnaud from the research and development department of Galderma, France, manufacturers of the clobetasol shampoo, led the trial, and the findings were presented in a poster here on March 22nd at the 61st Annual Meeting of the American Academy of Dermatology (AAD). Total Severity Score (TSS), determined by adding scores that reflected severity of erythema, plaque thickening and desquamation and Global Severity Scores (GSS) were both significantly better for the patients using the clobetasol shampoo than the tar shampoo at the end of the trial (p<0.001). Average TSS was reduced from 6.1 to 3.1 (on a 9-point scale) among patients using the clobetasol shampoo, compared with 6.2 to 5.3 among those using the tar shampoo. GSS dropped from 3.4 to 1.9 (on a 6-point scale) in patients using clobetasol shampoo, compared with 3.5 to 3.0 for those using the tar shampoo. Side effects monitored by the researchers included telangiectasia, skin atrophy and ocular safety. There was no difference between the two products with respect to these parameters. Clobetasol shampoo received better ratings on the Cosmetic Acceptability questionnaire, as filled out by the participants, than the tar shampoo. According to the authors, clobetasol proprionate 0.05% shampoo is superior to a tar blend shampoo for the treatment of moderate to severe scalp psoriasis. Also, short-term use of this agent is unlikely to cause any corticosteroid-induced adverse events, such as telangiectasia or skin atrophy. E-mail this page to a friend or colleague! To print, use this version